Tower Research Capital (TRC)’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52K | Sell |
1,105
-1,693
| -61% | -$6.92K | ﹤0.01% | 4314 |
|
|
2025
Q1 | $4.81K | Buy |
2,798
+199
| +8% | +$342 | ﹤0.01% | 4192 |
|
|
2024
Q4 | $3.82K | Sell |
2,599
-192
| -7% | -$282 | ﹤0.01% | 4584 |
|
|
2024
Q3 | $4.77K | Sell |
2,791
-882
| -24% | -$1.51K | ﹤0.01% | 4428 |
|
|
2024
Q2 | $7.75K | Sell |
3,673
-728
| -17% | -$1.54K | ﹤0.01% | 4430 |
|
|
2024
Q1 | $9.64K | Buy |
4,401
+1,907
| +76% | +$4.18K | ﹤0.01% | 3821 |
|
|
2023
Q4 | $8.63K | Buy |
2,494
+2,268
| +1,004% | +$7.85K | ﹤0.01% | 4486 |
|
|
2023
Q3 | $334 | Sell |
226
-328
| -59% | -$485 | ﹤0.01% | 5600 |
|
|
2023
Q2 | $859 | Sell |
554
-10,856
| -95% | -$16.8K | ﹤0.01% | 5503 |
|
|
2023
Q1 | $12K | Sell |
11,410
-1,712
| -13% | -$1.8K | ﹤0.01% | 4105 |
|
|
2022
Q4 | $15K | Sell |
13,122
-1,114
| -8% | -$1.27K | ﹤0.01% | 3435 |
|
|
2022
Q3 | $13K | Buy |
14,236
+4,932
| +53% | +$4.5K | ﹤0.01% | 4277 |
|
|
2022
Q2 | $14K | Buy |
9,304
+8,856
| +1,977% | +$13.3K | ﹤0.01% | 4152 |
|
|
2022
Q1 | $2K | Buy |
448
+371
| +482% | +$1.66K | ﹤0.01% | 5575 |
|
|
2021
Q4 | $0 | Buy |
+77
| New | – | ﹤0.01% | 6417 |
|
|
2021
Q3 | – | Sell |
-350
| Closed | -$3K | – | 6026 |
|
|
2021
Q2 | $3K | Sell |
350
-1
| -0.3% | -$9 | ﹤0.01% | 4939 |
|
|
2021
Q1 | $2K | Buy |
+351
| New | +$2K | ﹤0.01% | 5032 |
|
|
2020
Q4 | – | Sell |
-1,391
| Closed | -$10K | – | 5319 |
|
|
2020
Q3 | $10K | Buy |
1,391
+1,376
| +9,173% | +$9.89K | ﹤0.01% | 4097 |
|
|
2020
Q2 | $0 | Sell |
15
-267
| -95% | – | ﹤0.01% | 4897 |
|
|
2020
Q1 | $2K | Buy |
+282
| New | +$2K | ﹤0.01% | 2609 |
|